Mental Health Screening AdherenceNCT07322042
Evaluating Screening Adherence Between Moment for Parents App and Attention Control
A study testing Perinatal Psychoeducation Articles, Bi-weekly Perinatal Mental Health Screening and Chatbot-Guided Journaling in people with Mental Health Screening Adherence, run by Poisera, Inc. at 1 site in United States.
Trial summary
Mental health challenges, such as depression and anxiety, are the most common medical complications during pregnancy and after childbirth. Many women experience these symptoms, yet half are never screened, let alone diagnosed. Read more about this study
- Who is it for?
- Ages 18 years and older, women onlyHealthy volunteers can take part
- Conditions the study is for
- Mental Health Screening Adherence
- What is being tested?
- Perinatal Psychoeducation Articles, Bi-weekly Perinatal Mental Health Screening and Chatbot-Guided Journaling
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 160 participants
- Where
- 1 siteUnited States
- Study dates
- 5 Feb 2026to Aug 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Women who are:
- Pregnant or up to 1 year postpartum
- Age 18 years or older
- Lives in Michigan
- Owns a smartphone with internet access
- Proficient in English
Who cannot join
- Not female
- Not currently pregnant or more than 1 year postpartum
- Younger than 18 years old
- Does not live in Michigan
- Does not own a smartphone with internet access
- Not proficient in English
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
Remote/Virtual Participation
Ann Arbor, Michigan, 48109
Marianna Kerppola, 734-210-1120, team@momentforparents.com
About this study
Mental health challenges, such as depression and anxiety, are the most common medical complications during pregnancy and after childbirth. Many women experience these symptoms, yet half are never screened, let alone diagnosed. When mental health concerns go unnoticed, they can affect a mother's well-being, her birth experience, and her child's development. When identified early, these conditions are treatable. However, current healthcare practices often fail to screen women consistently, and many women do not feel comfortable discussing emotional struggles with healthcare providers.
This study will test whether a mobile app called Moment for Parents can help pregnant and postpartum women complete mental health screenings more regularly. The app includes educational articles, guided reflections, and mood check-ins that help women explore their feelings in a private, supportive environment. The app also includes a chatbot that guides them through short lessons about motherhood, stress, relationships, and emotional well-being. These conversations are designed to feel friendly and relatable, like talking with a knowledgeable companion rather than filling out a medical form. The investigators expect that this more personal experience may make it easier for women to notice and track changes in their mental health and encourage them to complete regular screeners.
Read more
The study will enroll 160 women who are pregnant or within the first year after giving birth. Participants will be randomly assigned to one of two groups:
Intervention group: Uses the full Moment for Parents app, including the interactive chatbot.
Control group: Uses a simplified version of the app with weekly articles but no chatbot.
Both groups will receive mental health screenings through the app over a 12-week period. These screenings include standard, widely used questionnaires that measure symptoms of depression and anxiety.
If a participant's answers show signs of concerning symptoms, such as depression, anxiety, or thoughts of self-harm, the study team will connect her to licensed mental health professionals for support. This offers more rapid help than the current standard of care, which often screens women only once during pregnancy.
The investigators hypothesize that women who interact with the chatbot version of the Moment for Parents app will complete mental health screenings twice as often as women using the app without the chatbot. In other words, the investigators believe the chatbot will increase regular screening by creating a more engaging and supportive experience.
Increasing the number of completed mental health screenings could help identify emotional struggles earlier, when treatment is most effective. If this study shows that the Moment for Parents app improves screening and engagement, it could guide the design of a larger study and help shape future care for pregnant and postpartum women nationwide. Overall, this research aims to make mental health support more accessible, less stigmatizing, and easier to use.
Read the detailed description
This study is a 12-week, two-arm pilot randomized controlled trial (RCT) designed to evaluate whether an interactive mobile application, the Moment for Parents app, improves adherence to routine mental health screening among pregnant and postpartum women. Perinatal mood and anxiety disorders (PMADs) are prevalent, impactful on maternal and infant health, and often remain undetected due to stigma, inconsistent clinical screening practices, and limited engagement with healthcare systems. Digital screening embedded within a consumer-facing app may address these barriers by normalizing emotional check-ins, reducing self-presentation concerns, and enabling repeated screening opportunities over time.
Participants will be randomized 1:1 to either (1) the Moment for Parents chatbot intervention arm or (2) an attention control arm. Randomization will occur automatically at enrollment using permuted block randomization with a fixed block size to ensure balanced allocation across key baseline characteristics (e.g., race, gestational age, mental health history). Because all data are collected through the app platform, independent assessor blinding is not required.
The intervention arm receives the fully developed Moment for Parents application, which includes interactive chatbot-guided lessons, reflective prompts, mood check-ins, and optional audio-based meditations. These components are organized into topic-based "Journeys," each composed of short lessons designed to be completed in approximately five minutes. The chatbot integrates validated mental health screeners (PHQ-9 and GAD-7) within regular mood check-ins, allowing screening to be delivered contextually rather than as a standalone questionnaire. Participants receive daily push notifications encouraging continued engagement.
The control arm receives a modified version of the Moment for Parents app that omits the chatbot and interactive lesson structure. Instead, users receive weekly push notifications linking to educational articles describing expected changes during pregnancy and postpartum, including infant development and maternal physical and emotional adjustments. Like the intervention arm, mental health screening is administered via the app algorithm at regular intervals, ensuring both groups receive equivalent exposure to screening opportunities.
The primary focus of the trial is to compare screening adherence trajectories between arms. Both the timing and frequency of PHQ-9 and GAD-7 administration exceed current clinical norms, which typically involve only one screening during the perinatal period. Screening and engagement metrics are passively captured through the app backend, allowing complete ascertainment of screening adherence without missing data due to participant attrition.
Participants who exceed clinical cutoffs for depression, anxiety, or suicidality will be automatically flagged via an application programming interface (API) that alerts a licensed behavioral health team affiliated with the MC3 Perinatal Program. This clinical escalation pathway includes structured risk assessment and, when indicated, facilitated linkage to psychiatric care. These clinical procedures are not part of the research intervention itself and are governed by independent IRB oversight within the MC3 program.
In addition to comparing screening adherence between arms, the study will evaluate user engagement behaviors, identify participant-level predictors of engagement, and explore patterns of app utilization over time. Quantitative app usage data, such as screens completed, content viewed, and activities initiated, will be analyzed alongside qualitative interview data from participants demonstrating high product affinity. These findings will inform optimization of the intervention and guide sample stratification strategies for a future, fully powered Phase II randomized trial.
The proposed research aims to address a major gap in perinatal mental health care by testing whether a mobile behavioral health tool can feasibly support sustained screening adherence outside of clinical environments. If successful, this approach may enable earlier identification of PMAD symptoms, reduce disparities in detection and treatment, and provide empirical evidence supporting digital engagement pathways for perinatal mental health monitoring at scale.
- Conditions
- Mental Health Screening Adherence
- Being tested
- Perinatal Psychoeducation Articles, Bi-weekly Perinatal Mental Health Screening, Chatbot-Guided Journaling, Perinatal-Focused Meditations, Themed Perinatal Learning Pathways
- Keywords
- maternal mental health, perinatal mood and anxiety disorders
- Medical subject headings
- Anxiety Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Perinatal Psychoeducation ArticlesBehavioural
Participants access brief, evidence-based articles related to pregnancy, postpartum experiences, and infant development. Articles are designed to increase perinatal knowledge and normalize common emotional and physical changes during this period.
Bi-weekly Perinatal Mental Health ScreeningBehavioural
Participants complete validated mental health screening tools (PHQ-9 and GAD-7) integrated into a mobile app. This allows screening to occur in a non-clinical, routine format and increases opportunities for early symptom identification.
Chatbot-Guided JournalingBehavioural
Participants interact with a conversational chatbot that guides them through mood reflection prompts, journaling activities, and emotional processing exercises. The chatbot personalizes the experience using user input and delivers supportive, non-clinical language to reduce barriers to disclosure.
Perinatal-Focused MeditationsBehavioural
Participants are provided optional audio-based mindfulness and self-regulation meditations tailored to pregnancy and postpartum stressors. These meditations support emotional regulation and help participants manage worry, fatigue, and distress.
Themed Perinatal Learning PathwaysBehavioural
Participants select topic-based curricula (called "Journeys") composed of brief lessons that include educational content, reflections, and optional activities. Each pathway focuses on a specific aspect of pregnancy or postpartum well-being (e.g., resilience, social support, communication with clinicians) and prompts sustained engagement through short, sequential modules.
| Study group | Role | What they receive |
|---|---|---|
| Moment for Parents Intervention | Experimental | Participants in the intervention arm will use the full Moment for Parents mobile application, which includes an interactive chatbot that delivers brief lessons, mood check-ins, guided reflections, and optional mindfulness activities. Lessons are grouped into topic-based "Journeys," each consisting of short modules designed to support emotional well-being during pregnancy and postpartum. The app sends daily push notifications prompting users to continue their Journey or engage with mood-related activities. Standard mental health screening instruments (PHQ-9 and GAD-7) are integrated into these check-ins, allowing screening to occur naturally within regular app use. The intervention is designed to increase user engagement and create more opportunities for mental health screening completion than traditional perinatal care. Receives: Behavioral: Perinatal Psychoeducation Articles; Behavioral: Bi-weekly Perinatal Mental Health Screening; Behavioral: Chatbot-Guided Journaling; Behavioral: Perinatal-Focused Meditations; Behavioral: Themed Perinatal Learning Pathways |
| Moment for Parents Attention Control | Sham comparator | Participants in the attention control arm will use a modified version of the Moment for Parents mobile application that does not include the interactive chatbot or guided "Journey" lessons. Instead, the app sends weekly push notifications prompting users to read brief educational articles on pregnancy and postpartum topics, including infant development and common maternal experiences. The app delivers the same mental health screeners (PHQ-9 and GAD-7) at comparable intervals as the intervention arm. However, the screeners are not embedded within conversational features. This version of the app provides exposure to perinatal health information without the personalized engagement strategies present in the intervention condition. Receives: Behavioral: Perinatal Psychoeducation Articles; Behavioral: Bi-weekly Perinatal Mental Health Screening |
What is being measured
The primary outcome is the main question the study is designed to answer.
Mental Health Screening Adherence
Mental health screening adherence will be measured as the total number of completed PHQ-9 and GAD-7 screenings delivered through the Moment for Parents app during the 12-week study period. Screening opportunities occur bi-weekly and are recorded passively by the application backend, allowing precise tracking of whether a participant completed each scheduled screening. Adherence will be compared across study arms using count-based analysis methods to determine whether the interactive chatbot increases screening adherence relative to the attention control condition.
Measured: From enrollment to 12 weeks post-enrollment
Secondary outcomes (6)
App Engagement
Engagement will be measured using backend app analytics, including counts of completed chatbot conversations, articles read, meditations accessed, and activities saved. Engagement rate will be calculated as the average number of activities completed per active user within each weekly interval.
Measured: From enrollment to 12 weeks post-enrollment
App Retention
App retention will be measured as the length of time a participant continues to actively engage with the Moment for Parents application from initial use until the final recorded activity (e.g., chatbot interaction, article read, or meditation completed). Retention patterns will be analyzed to determine how long participants remain active in the app environment and whether retention differs between study arms or varies by baseline characteristics such as mental health history or initial engagement levels.
Measured: From enrollment to 12 weeks post-enrollment
Baseline Predictors of Screening Adherence
We will use Cox proportional hazards regression to examine predictors, including demographics, mental health history, and baseline PHQ-9 and GAD-7 score. As above, the starting point will be when the participant enrolls in the study and completes the first PHQ-9 and GAD-7 screen, and the endpoint will be when she completes her final PHQ-9 and GAD-7 screen. The proportional hazards assumption will be tested for each predictor by including the interaction between the predictor and time. If the interaction term is significant, we will include it in the final model to account for the non-proportional hazards. For each predictor, we will report the odds ratio with 95% CI.
Measured: From enrollment to 12 weeks post-enrollment
Patterns of Mental Health Screening Behavior
Patterns of screening behavior will be evaluated by modeling the binary outcome of whether participants complete the PHQ-9 and GAD-7 screeners each week using a generalized linear mixed-effects model with a logit link. Graphical analyses of fitted model estimates over the 12-week period will be used to identify distinct user subgroups (e.g., "early adopters," "infrequent responders," and "compliers") based on trajectories of screening completion. Comparisons will be made between study arms and across participant characteristics (such as baseline mental health history and initial screening scores) to determine whether these factors are associated with differing patterns of screening behavior.
Measured: From enrollment to 12 weeks post-enrollment
Perceived Value of the Moment for Parents App
Using a four-item product-market fit survey, participants will report perceived benefit, emotional response if access were removed, and suggested improvements. Responses from the "Very disappointed" subgroup will be used to identify the characteristics of users who perceive high value.
Measured: From 1 week after enrollment through 12 weeks after enrollment
Thematic Insights from User Experience Interviews
Semi-structured interviews with participants who report being "very disappointed" at the prospect of losing access to the app will be analyzed using inductive thematic analysis to identify common needs, experiences, and features associated with meaningful engagement.
Measured: From 1 week after enrollment through 3 months after enrollment
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Jan 2026
- Study start5 Feb 2026
- Primary completionJun 2026 (estimated)
- Study completionAug 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Mental Health Screening AdherenceStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Screening
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Care provider
- Enrolment
- 160 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Poisera, Inc.
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- University of Michigan, National Institute of Mental Health (NIMH)
- Responsible party
- Sponsor
- Investigators
- Marianna Kerppola, MBA, MSc, Principal investigator, Poisera, Inc.Maria Muzik, MD, MSc, Principal investigator, University of Michigan
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07322042
- Sponsor's protocol ID
- R43MH130293
- Other IDs
- R43MH130293
- Status last verified
- Mar 2026
- First submitted
- 8 Dec 2025
- Last updated
- 6 Mar 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Individual participant data (IPD) will be shared in de-identified form for the primary and secondary outcome measures described in the study protocol. All identifiers (such as names, contact information, and geographic data that could permit re-identification) will be removed prior to sharing. De-identified datasets will include only outcome variables and relevant demographic variables needed for reproducibility. Data will be made available upon reasonable request to qualified researchers whose proposed use is consistent with the goals of the study and who agree to comply with data use and confidentiality requirements. Data will be provided after study completion and primary results publication. No identifiable information collected as part of the Moment for Parents platform or clinical escalation procedures will be shared.
Study at a glance
From the registry record, last updated by the sponsor on 6 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluating Screening Adherence Between Moment for Parents App and Attention Control
- ClinicalTrials.gov ID
- NCT07322042
- Acronym / sponsor ID
- R43MH130293
- Conditions
- Mental Health Screening Adherence
- Keywords
- maternal mental health, perinatal mood and anxiety disorders
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 160 participants (estimated)
- Lead sponsor
- Poisera, Inc.Industry (pharma, biotech, devices)
- Collaborators
- University of Michigan, National Institute of Mental Health (NIMH)
- Study start
- 5 Feb 2026 (actual)
- Primary completion
- Jun 2026 (estimated)
- Study completion
- Aug 2026 (estimated)
- First posted
- 7 Jan 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Mental health challenges, such as depression and anxiety, are the most common medical complications during pregnancy and after childbirth. Many women experience these symptoms, yet half are never screened, let alone diagnosed. When mental health concerns go unnoticed, they can affect a mother's well-being, her birth experience, and her child's development. When identified early, these conditions are treatable. However, current healthcare practices often fail to screen women consistently, and many women do not feel comfortable discussing emotional struggles with healthcare providers.
This study will test whether a mobile app called Moment for Parents can help pregnant and postpartum women complete mental health screenings more regularly. The app includes educational articles, guided reflections, and mood check-ins that help women explore their feelings in a private, supportive environment. The app also includes a chatbot that guides them through short lessons about motherhood, stress, relationships, and emotional well-being. These conversations are designed to feel friendly and relatable, like talking with a knowledgeable companion rather than filling out a medical form. The investigators expect that this more personal experience may make it easier for women to notice and track changes in their mental health and encourage them to complete regular screeners.
The study will enroll 160 women who are pregnant or within the first year after giving birth. Participants will be randomly assigned to one of two groups:
Intervention group: Uses the full Moment for Parents app, including the interactive chatbot.
Control group: Uses a simplified version of the app with weekly articles but no chatbot.
Both groups will receive mental health screenings through the app over a 12-week period. These screenings include standard, widely used questionnaires that measure symptoms of depression and anxiety.
If a participant's answers show signs of concerning symptoms, such as depression, anxiety, or thoughts of self-harm, the study team will connect her to licensed mental health professionals for support. This offers more rapid help than the current standard of care, which often screens women only once during pregnancy.
The investigators hypothesize that women who interact with the chatbot version of the Moment for Parents app will complete mental health screenings twice as often as women using the app without the chatbot. In other words, the investigators believe the chatbot will increase regular screening by creating a more engaging and supportive experience.
Increasing the number of completed mental health screenings could help identify emotional struggles earlier, when treatment is most effective. If this study shows that the Moment for Parents app improves screening and engagement, it could guide the design of a larger study and help shape future care for pregnant and postpartum women nationwide. Overall, this research aims to make mental health support more accessible, less stigmatizing, and easier to use.
Detailed description
This study is a 12-week, two-arm pilot randomized controlled trial (RCT) designed to evaluate whether an interactive mobile application, the Moment for Parents app, improves adherence to routine mental health screening among pregnant and postpartum women. Perinatal mood and anxiety disorders (PMADs) are prevalent, impactful on maternal and infant health, and often remain undetected due to stigma, inconsistent clinical screening practices, and limited engagement with healthcare systems. Digital screening embedded within a consumer-facing app may address these barriers by normalizing emotional check-ins, reducing self-presentation concerns, and enabling repeated screening opportunities over time.
Participants will be randomized 1:1 to either (1) the Moment for Parents chatbot intervention arm or (2) an attention control arm. Randomization will occur automatically at enrollment using permuted block randomization with a fixed block size to ensure balanced allocation across key baseline characteristics (e.g., race, gestational age, mental health history). Because all data are collected through the app platform, independent assessor blinding is not required.
The intervention arm receives the fully developed Moment for Parents application, which includes interactive chatbot-guided lessons, reflective prompts, mood check-ins, and optional audio-based meditations. These components are organized into topic-based "Journeys," each composed of short lessons designed to be completed in approximately five minutes. The chatbot integrates validated mental health screeners (PHQ-9 and GAD-7) within regular mood check-ins, allowing screening to be delivered contextually rather than as a standalone questionnaire. Participants receive daily push notifications encouraging continued engagement.
The control arm receives a modified version of the Moment for Parents app that omits the chatbot and interactive lesson structure. Instead, users receive weekly push notifications linking to educational articles describing expected changes during pregnancy and postpartum, including infant development and maternal physical and emotional adjustments. Like the intervention arm, mental health screening is administered via the app algorithm at regular intervals, ensuring both groups receive equivalent exposure to screening opportunities.
The primary focus of the trial is to compare screening adherence trajectories between arms. Both the timing and frequency of PHQ-9 and GAD-7 administration exceed current clinical norms, which typically involve only one screening during the perinatal period. Screening and engagement metrics are passively captured through the app backend, allowing complete ascertainment of screening adherence without missing data due to participant attrition.
Participants who exceed clinical cutoffs for depression, anxiety, or suicidality will be automatically flagged via an application programming interface (API) that alerts a licensed behavioral health team affiliated with the MC3 Perinatal Program. This clinical escalation pathway includes structured risk assessment and, when indicated, facilitated linkage to psychiatric care. These clinical procedures are not part of the research intervention itself and are governed by independent IRB oversight within the MC3 program.
In addition to comparing screening adherence between arms, the study will evaluate user engagement behaviors, identify participant-level predictors of engagement, and explore patterns of app utilization over time. Quantitative app usage data, such as screens completed, content viewed, and activities initiated, will be analyzed alongside qualitative interview data from participants demonstrating high product affinity. These findings will inform optimization of the intervention and guide sample stratification strategies for a future, fully powered Phase II randomized trial.
The proposed research aims to address a major gap in perinatal mental health care by testing whether a mobile behavioral health tool can feasibly support sustained screening adherence outside of clinical environments. If successful, this approach may enable earlier identification of PMAD symptoms, reduce disparities in detection and treatment, and provide empirical evidence supporting digital engagement pathways for perinatal mental health monitoring at scale.
Study design
- Primary purpose
- Screening
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, care provider)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Moment for Parents Intervention | Experimental | Behavioral: Perinatal Psychoeducation Articles, Behavioral: Bi-weekly Perinatal Mental Health Screening, Behavioral: Chatbot-Guided Journaling, Behavioral: Perinatal-Focused Meditations, Behavioral: Themed Perinatal Learning PathwaysParticipants in the intervention arm will use the full Moment for Parents mobile application, which includes an interactive chatbot that delivers brief lessons, mood check-ins, guided reflections, and optional mindfulness activities. Lessons are grouped into topic-based "Journeys," each consisting of short modules designed to support emotional well-being during pregnancy and postpartum. The app sends daily push notifications prompting users to continue their Journey or engage with mood-related activities. Standard mental health screening instruments (PHQ-9 and GAD-7) are integrated into these check-ins, allowing screening to occur naturally within regular app use. The intervention is designed to increase user engagement and create more opportunities for mental health screening completion than traditional perinatal care. |
| Moment for Parents Attention Control | Sham comparator | Behavioral: Perinatal Psychoeducation Articles, Behavioral: Bi-weekly Perinatal Mental Health ScreeningParticipants in the attention control arm will use a modified version of the Moment for Parents mobile application that does not include the interactive chatbot or guided "Journey" lessons. Instead, the app sends weekly push notifications prompting users to read brief educational articles on pregnancy and postpartum topics, including infant development and common maternal experiences. The app delivers the same mental health screeners (PHQ-9 and GAD-7) at comparable intervals as the intervention arm. However, the screeners are not embedded within conversational features. This version of the app provides exposure to perinatal health information without the personalized engagement strategies present in the intervention condition. |
Who may qualify
- Ages
- 18 years and older
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- Pregnant or up to 1 year postpartum
- Age 18 years or older
- Lives in Michigan
- Owns a smartphone with internet access
- Proficient in English
Key exclusion criteria (6 listed)
- Not female
- Not currently pregnant or more than 1 year postpartum
- Younger than 18 years old
- Does not live in Michigan
- Does not own a smartphone with internet access
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Perinatal Psychoeducation ArticlesParticipants access brief, evidence-based articles related to pregnancy, postpartum experiences, and infant development. Articles are designed to increase perinatal knowledge and normalize common emotional and physical changes during this period. | Behavioural | Moment for Parents Attention Control, Moment for Parents Intervention |
| Bi-weekly Perinatal Mental Health ScreeningParticipants complete validated mental health screening tools (PHQ-9 and GAD-7) integrated into a mobile app. This allows screening to occur in a non-clinical, routine format and increases opportunities for early symptom identification. | Behavioural | Moment for Parents Attention Control, Moment for Parents Intervention |
| Chatbot-Guided JournalingParticipants interact with a conversational chatbot that guides them through mood reflection prompts, journaling activities, and emotional processing exercises. The chatbot personalizes the experience using user input and delivers supportive, non-clinical language to reduce barriers to disclosure. | Behavioural | Moment for Parents Intervention |
| Perinatal-Focused MeditationsParticipants are provided optional audio-based mindfulness and self-regulation meditations tailored to pregnancy and postpartum stressors. These meditations support emotional regulation and help participants manage worry, fatigue, and distress. | Behavioural | Moment for Parents Intervention |
| Themed Perinatal Learning PathwaysParticipants select topic-based curricula (called "Journeys") composed of brief lessons that include educational content, reflections, and optional activities. Each pathway focuses on a specific aspect of pregnancy or postpartum well-being (e.g., resilience, social support, communication with clinicians) and prompts sustained engagement through short, sequential modules. | Behavioural | Moment for Parents Intervention |
Primary outcome
Mental Health Screening Adherence
Time frame: From enrollment to 12 weeks post-enrollment
Mental health screening adherence will be measured as the total number of completed PHQ-9 and GAD-7 screenings delivered through the Moment for Parents app during the 12-week study period. Screening opportunities occur bi-weekly and are recorded passively by the application backend, allowing precise tracking of whether a participant completed each scheduled screening. Adherence will be compared across study arms using count-based analysis methods to determine whether the interactive chatbot increases screening adherence relative to the attention control condition.
6 secondary outcomes
App Engagement
Time frame: From enrollment to 12 weeks post-enrollment
App Retention
Time frame: From enrollment to 12 weeks post-enrollment
Baseline Predictors of Screening Adherence
Time frame: From enrollment to 12 weeks post-enrollment
Patterns of Mental Health Screening Behavior
Time frame: From enrollment to 12 weeks post-enrollment
Perceived Value of the Moment for Parents App
Time frame: From 1 week after enrollment through 12 weeks after enrollment
Thematic Insights from User Experience Interviews
Time frame: From 1 week after enrollment through 3 months after enrollment
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Mar 2026.
- Study Recruitment and Enrollment InformationLink provided by the sponsor.
- Individual participant dataSharing planned: Yes. Individual participant data (IPD) will be shared in de-identified form for the primary and secondary outcome measures described in the study protocol. All identifiers (such as names, contact information, and geographic data that could permit re-identification) will be removed prior to sharing. De-identified datasets will include only outcome variables and relevant demographic variables needed for reproducibility. Data will be made available upon reasonable request to qualified researchers whose proposed use is consistent with the goals of the study and who agree to comply with data use and confidentiality requirements. Data will be provided after study completion and primary results publication. No identifiable information collected as part of the Moment for Parents platform or clinical escalation procedures will be shared.
Related trials for Mental Health Screening Adherence
Not yet recruiting
Cervical Cancer Awareness Education to Aid Confidence and Screening upTake (ACT): A Pilot Randomised Control Trial
Anxiety, Cervical Cancer Screening
Recruiting
Health Ahead Comparative Effectiveness Study
Health Services Accessibility, Rural Health
Not yet recruiting
proState Cancer Health Education to pRomote Early sreENing Uptake (SCREEN): A Pilot Randomised Control Trial
Anxiety, Prostate Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Marianna Kerppola, MBA, MSc principal investigator
Poisera, Inc.
Maria Muzik, MD, MSc principal investigator
University of Michigan
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Perinatal Psychoeducation Articles, Bi-weekly Perinatal Mental Health Screening and Chatbot-Guided Journaling in people with Mental Health Screening Adherence, run by Poisera, Inc. at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 6 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Marianna Kerppola (734-210-1120, team@momentforparents.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Mental Health Screening Adherence (time frame: From enrollment to 12 weeks post-enrollment). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Mar 2026.